Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer

NCT04692675 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT04692675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04692675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
Lead sponsor
National Cancer Institute (NCI)
Phase
Not applicable
Overall status
Recruiting
Start date
November 18, 2022
Completion date
September 1, 2031
Enrollment
508 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer